Aurinia Pharmaceuticals Inc Net Income per Employee (AUPH), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Aurinia Pharmaceuticals Inc   (NASDAQ: AUPH)
 

Aurinia Pharmaceuticals Inc Net Income per Employee

AUPH's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 73.91% in the second quarter 2026, year on year to cumulative value of $314 million, and with 128 employees, Aurinia Pharmaceuticals Inc 's income per employee grew on trailing twelve month basis to $ 2,454,016, this marks a new company high for all of 128 employees.
The Healthcare sector has seen employees of 10 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 91, from total ranking in previous quarter at 127.


What is Income per Employee Ratio?






AUPH Net Income per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Net Income Change 73.91 % 47.17 % 14651.15 % 119.87 % 2879.64 %
Net Income per Employee (TTM) $ 2,454,016 2,329,789 2,243,766 608,102 473,719
AUPH's Total Ranking # 91 # 127 # 278 # 302 # 389
Seq. Net Income Change 8.9 % -83.7 % 568.11 % 46.66 % -7.84 %


AUPH Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 11
Healthcare Sector # 11
Overall Market # 91

Net Income per Employee Statistics
High Average Low
$ 2,454,016 $ -248,395 $ -1,413,797
(Jun 30 2026)   (Dec 31 2021)







Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2026Number of Employees Jun 30 2026
Ligand Pharmaceuticals Incorporated  4,196,170.21 $ 197.220  Million 47 
Rallybio Corporation  3,253,642.86 $ 45.551  Million 14 
Aurinia Pharmaceuticals Inc   2,454,015.63 $ 314.114  Million 128 
Innoviva Inc   2,246,767.30 $ 357.236  Million 159 
Quince Therapeutics Inc   2,060,342.11 $ 78.293  Million 38 
Fortress Biotech Inc   2,030,307.69 $ 158.364  Million 78 
Elutia Inc   1,992,615.38 $ 51.808  Million 26 
Rigel Pharmaceuticals Inc  1,850,051.72 $ 321.909  Million 174 
Exelixis Inc   1,653,085.44 $ 1,896.089  Million 1,147 
Actinium Pharmaceuticals Inc  1,514,120.00 $ 37.853  Million 25 
Q32 Bio Inc   1,407,750.00 $ 33.786  Million 24 
Ironwood Pharmaceuticals inc   1,298,680.00 $ 129.868  Million 100 


Date modified: 2026-09-08T16:39:17+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.